Search research articles
Contact Us
Filters
Showing results (51-60 of 80) with videos related to
Page
of 8
Sort By:
Blood Advances
|
July 12, 2018
Analysis of carfilzomib cardiovascular safety profile across relapsed and/or refractory multiple myeloma clinical trials
Ajai Chari, A Keith Stewart, Stuart D Russell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 27, 2017
Outcomes from Autologous Hematopoietic Cell Transplantation versus Chemotherapy Alone for the Management of Light Chain Amyloidosis
Oluchi Oke, Tarsheen Sethi, Stacey Goodman, et al.
Clinical and Translational Science
|
May 24, 2024
Metabolomic signatures of carfilzomib-related cardiotoxicity in patients with multiple myeloma
Samia Shabnaz, Trang N Nguyen, Roy Williams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 16, 2017
Prospective Evaluation of Sunitinib-Induced Cardiotoxicity in Patients with Metastatic Renal Cell Carcinoma
Vivek Narayan, Stephen Keefe, Naomi Haas, et al.
American Heart Journal
|
February 7, 2012
Management of cardiac toxicity in patients receiving vascular endothelial growth factor signaling pathway inhibitors
Richard M Steingart, George L Bakris, Helen X Chen, et al.
Frontiers in Cardiovascular Medicine
|
July 6, 2023
Whole-Exome sequencing analysis identified TMSB10/TRABD2A locus to be associated with carfilzomib-related cardiotoxicity among patients with multiple myeloma
Marwa Tantawy, Guang Yang, Raghunandan Reddy Algubelli, et al.
Circulation
|
November 11, 2016
Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association
Biykem Bozkurt, Monica Colvin, Jennifer Cook, et al.
Clinical Pharmacology and Therapeutics
|
February 2, 2026
Causal Effects of Hydrophilic Bile Acids on Carfilzomib-Related Cardiovascular Events in Multiple Myeloma: A Mendelian Randomization Study
Samia Shabnaz, Eric Farber-Eger, Marwa Tantawy, et al.
JACC. Heart Failure
|
October 28, 2023
SGLT2 Inhibitor Use and Risk of Clinical Events in Patients With Cancer Therapy-Related Cardiac Dysfunction
Vennela Avula, Garima Sharma, Mikhail N Kosiborod, et al.
Psychosomatic Medicine
|
December 4, 2015
Depression and Oropharynx Cancer Outcome
Eileen H Shinn, Alan Valentine, Amit Jethanandani, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 80) with videos related to
Sort By:
Page
of 8
Blood Advances
|
July 12, 2018
Analysis of carfilzomib cardiovascular safety profile across relapsed and/or refractory multiple myeloma clinical trials
Ajai Chari, A Keith Stewart, Stuart D Russell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 27, 2017
Outcomes from Autologous Hematopoietic Cell Transplantation versus Chemotherapy Alone for the Management of Light Chain Amyloidosis
Oluchi Oke, Tarsheen Sethi, Stacey Goodman, et al.
Clinical and Translational Science
|
May 24, 2024
Metabolomic signatures of carfilzomib-related cardiotoxicity in patients with multiple myeloma
Samia Shabnaz, Trang N Nguyen, Roy Williams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 16, 2017
Prospective Evaluation of Sunitinib-Induced Cardiotoxicity in Patients with Metastatic Renal Cell Carcinoma
Vivek Narayan, Stephen Keefe, Naomi Haas, et al.
American Heart Journal
|
February 7, 2012
Management of cardiac toxicity in patients receiving vascular endothelial growth factor signaling pathway inhibitors
Richard M Steingart, George L Bakris, Helen X Chen, et al.
Frontiers in Cardiovascular Medicine
|
July 6, 2023
Whole-Exome sequencing analysis identified TMSB10/TRABD2A locus to be associated with carfilzomib-related cardiotoxicity among patients with multiple myeloma
Marwa Tantawy, Guang Yang, Raghunandan Reddy Algubelli, et al.
Circulation
|
November 11, 2016
Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association
Biykem Bozkurt, Monica Colvin, Jennifer Cook, et al.
Clinical Pharmacology and Therapeutics
|
February 2, 2026
Causal Effects of Hydrophilic Bile Acids on Carfilzomib-Related Cardiovascular Events in Multiple Myeloma: A Mendelian Randomization Study
Samia Shabnaz, Eric Farber-Eger, Marwa Tantawy, et al.
JACC. Heart Failure
|
October 28, 2023
SGLT2 Inhibitor Use and Risk of Clinical Events in Patients With Cancer Therapy-Related Cardiac Dysfunction
Vennela Avula, Garima Sharma, Mikhail N Kosiborod, et al.
Psychosomatic Medicine
|
December 4, 2015
Depression and Oropharynx Cancer Outcome
Eileen H Shinn, Alan Valentine, Amit Jethanandani, et al.
Page
of 8